Gross Margin
20.14%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 15.09%.Updated Sep 19, 2026Profit Margin
5.57%vs Specialty Chemicals peers Updated Sep 19, 2026Operating Margin
9.74%vs Specialty Chemicals peers Updated Sep 19, 2026Return on Assets (TTM)
2.48%vs Specialty Chemicals peers Updated Sep 19, 2026Return on Equity (TTM)
6.69%vs Specialty Chemicals peers Updated Sep 19, 2026Revenue (TTM)
1.41BCNY209.61M · vs all stocks (USD) Updated Sep 19, 2026Revenue per Share (TTM)
15.08CNYUpdated Sep 19, 2026Quarterly Revenue Growth
17.60%vs Specialty Chemicals peers Updated Sep 19, 2026Gross Profit (TTM)
212.07MCNY31.63M · vs all stocks (USD) Updated Sep 19, 2026EBITDA (TTM)
142.92MCNY21.32M · vs all stocks (USD) Updated Sep 19, 2026Net Income (TTM)
78.32MCNY11.68M · vs all stocks (USD) Updated Sep 19, 2026Quarterly Earnings Growth (YoY)
-0.70%vs Specialty Chemicals peers Updated Sep 19, 2026Operating Cash Flow (TTM)
78.98MCNY11.78M · vs all stocks (USD) Updated Sep 19, 2026Levered Free Cash Flow (TTM)
-249.22MCNY-37.17M · vs all stocks (USD) Updated Sep 19, 2026Trailing Annual Dividend Rate
0.1500CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
0.46%Updated Sep 19, 2026Payout Ratio
37.50%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 18.75%.Updated Sep 19, 2026Minority Interest (Equity)
59.04MCNYFY2025 · Dec 31, 2025Revenue
1.31BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.11BCNYFY2025 · Dec 31, 2025Gross Profit
197.96MCNYFY2025 · Dec 31, 2025Operating Income
71.86MCNY10.72M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
79.78MCNYFY2025 · Dec 31, 2025Income Tax Expense
11.38MCNYFY2025 · Dec 31, 2025Net Income
68.40MCNYFY2025 · Dec 31, 2025EBIT
86.65MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
150.54MCNYFY2025 · Dec 31, 2025Research & Development
14.77MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
48.25MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.51MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.87MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.9100CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.9100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
85.52MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
85.52MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
68.40MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
9.42MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
71.95MCNYFY2025 · Dec 31, 2025Free Cash Flow
-31.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
191.23MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
68.40MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.74MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
73.51MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-76.70MCNYFY2025 · Dec 31, 2025Capital Expenditures
-103.75MCNYFY2025 · Dec 31, 2025Purchase of Investments
-657.00MCNYFY2025 · Dec 31, 2025Sale of Investments
577.72MCNYFY2025 · Dec 31, 2025Other Investing Activity
-4.75MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-187.77MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
263.55MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-277.66MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-20.86MCNYFY2025 · Dec 31, 2025Other Financing Charges
245.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
210.11MCNYFY2025 · Dec 31, 2025